NCCN Guidelines Insights: Breast Cancer, Version 1.2017
Western University · Robert H. Lurie Comprehensive Cancer Center of Northwestern University · +45 more institutions
Abstract
These NCCN Guidelines Insights highlight the important updates/changes to the surgical axillary staging, radiation therapy, and systemic therapy recommendations for hormone receptor-positive disease in the 1.2017 version of the NCCN Guidelines for Breast Cancer. This report summarizes these updates and discusses the rationale behind them. Updates on new drug approvals, not available at press time, can be found in the most recent version of these guidelines at NCCN.org.
Citation impact
- FWCI
- 24.34
- Percentile
- 100%
- References
- 97
Authors
33- WJWilliam J. GradisharCorresponding
Western University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- BOBenjamin O. Anderson
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa, Fred Hutch Cancer Center, Seattle Cancer Care Alliance, Cancer Research Center
- RBRonald Balassanian
UCSF Helen Diller Family Comprehensive Cancer Center
- SLSarah L. Blair
Moores Cancer Center, University of California, San Diego, UC San Diego Health System
- HJHarold J. Burstein
Dana-Farber Brigham Cancer Center
Topics & keywords
- Medicine
- Breast cancer
- Radiation therapy
- Cancer
- Medical physics
- Systemic therapy
- Intensive care medicine
- Oncology
- Good health and well-being